Synthesis and Characterization of ULK1/2 Kinase Inhibitors That Inhibit Autophagy and Upregulate Expression of Major Histocompatibility Complex I for the Treatment of Non-Small Cell Lung Cancer
ACS Chemical Biology · 20.03.2026 · 21 (3) · 469-489
DOI: 10.1021/acschembio.5c00711 ↗Kurz gefasst
Fachartikel in der Zeitschrift ACS Chemical Biology, online erschienen am 12.02.2026. Verfasst von Fabiana Izidro A L Layng und 20 weiteren Autor:innen. Beteiligte Einrichtung: Center for Therapeutics Discovery, NCI-Designated Cancer Center, Sanford Burnham Prebys Medical Discovery Institute, La Jolla, California 92037, Unit…. Hauptthemen laut MEDLINE: Autophagy, Carcinoma, Non-Small-Cell Lung, Autophagy-Related Protein-1 Homolog, Protein Kinase Inhibitors. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 63 Literaturangaben. Gefördert von: NCI NIH HHS, Janssen Research and Development, National Cancer Institute.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Center for Therapeutics Discovery, NCI-Designated Cancer Center, Sanford Burnham Prebys Medical Discovery Institute, La Jolla, California 92037, United States.
- Structural Genomics Consortium, Buchmann Institute for Molecular Life Sciences, Goethe-University Frankfurt, Frankfurt 60438, Germany.
- Institute of Pharmaceutical Chemistry, Goethe-University Frankfurt, Frankfurt 60438, Germany.
- Molecular and Cell Biology Laboratory, The Salk Institute for Biological Studies, La Jolla, California 92037, United States.
ORCID-Profile: Lester J Lambert, Jiaqian Wu, Apirat Chaikuad, Stefan Knapp, Guy S Salvesen, Nicholas D P Cosford
Förderung
- NCI NIH HHS
- Janssen Research and Development
- National Cancer Institute
- Bayer
- Genentech
- Takeda Pharmaceutical Company
- Pfizer
- Bristol-Myers Squibb
Zitieren
APA
Layng, F. I. A. L., Ren, H., Bakas, N. A., Panickar, D. R., Lambert, L. J., Celeridad, M., Wu, J., De Backer, L., Chandrachud, P., Limpert, A. S., Vamos, M., Chaikuad, A., Verdugo, B. B., Hagan, P. M., Brun, S. N., Tautz, L., Knapp, S., Shaw, R. J., Salvesen, G. S., …, & Cosford, N. D. P. (2026). Synthesis and Characterization of ULK1/2 Kinase Inhibitors That Inhibit Autophagy and Upregulate Expression of Major Histocompatibility Complex I for the Treatment of Non-Small Cell Lung Cancer. ACS Chemical Biology, 21(3), 469-489. https://doi.org/10.1021/acschembio.5c00711
Vancouver
Layng FIAL, Ren H, Bakas NA, Panickar DR, Lambert LJ, Celeridad M, et al. Synthesis and Characterization of ULK1/2 Kinase Inhibitors That Inhibit Autophagy and Upregulate Expression of Major Histocompatibility Complex I for the Treatment of Non-Small Cell Lung Cancer. ACS Chemical Biology. 2026;21(3):469-489. doi:10.1021/acschembio.5c00711
BibTeX
@article{Layng2026,
author = {Layng, Fabiana Izidro A L and Ren, Huiyu and Bakas, Nicole A and Panickar, Dhanya R and Lambert, Lester J and Celeridad, Maria and Wu, Jiaqian and De Backer, Laurent and Chandrachud, Preeti and Limpert, Allison S and Vamos, Mitchell and Chaikuad, Apirat and Verdugo, Betsaida B and Hagan, Patrick M and Brun, Sonja N and Tautz, Lutz and Knapp, Stefan and Shaw, Reuben J and Salvesen, Guy S and Sheffler, Douglas J and Cosford, Nicholas D P},
title = {Synthesis and Characterization of ULK1/2 Kinase Inhibitors That Inhibit Autophagy and Upregulate Expression of Major Histocompatibility Complex I for the Treatment of Non-Small Cell Lung Cancer},
journal = {ACS Chemical Biology},
year = {2026},
volume = {21},
number = {3},
pages = {469--489},
doi = {10.1021/acschembio.5c00711}
}
EUVIMED